Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity

The waning effectiveness of the primary vaccination for SARS-CoV-2 led to administration of an additional booster dose (BD). The efficacy of the BD in stimulating humoral systemic immune response is well established, but its effectiveness on inducing mucosal immune reaction has not yet been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambiase, Alessandro, Sacchetti, Marta, Mallone, Fabiana, Tirassa, Paola, Greco, Antonio, Angeloni, Antonio, Polimeni, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598907/
https://www.ncbi.nlm.nih.gov/pubmed/36289692
http://dx.doi.org/10.3390/biomedicines10102430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598907/
https://www.ncbi.nlm.nih.gov/pubmed/36289692
http://dx.doi.org/10.3390/biomedicines10102430

Ejemplares similares